Ligand validation:5BXR

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 5BXR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5BXR_GAL_A_701	80%	41%	0.074	0.938	1.03	1.27	-	1	0	0	92%	0.9167
5BXR_GAL_B_701	79%	39%	0.088	0.949	1.12	1.25	-	2	0	0	92%	0.9167
5BXT_GAL_B_704	84%	41%	0.083	0.96	0.89	1.37	-	2	0	0	92%	0.9167
4JAW_GAL_B_701	81%	34%	0.09	0.957	1.49	1.12	2	-	0	0	92%	0.9167
5BXS_GAL_B_701	63%	31%	0.114	0.922	1.02	1.72	-	5	1	0	92%	0.9167
4WWH_GAL_B_401	100%	61%	0.027	0.99	0.5	0.97	-	1	0	0	100%	1
5ELB_GAL_C_202	100%	58%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1
4LKF_GAL_A_201	98%	55%	0.045	0.984	0.92	0.83	-	-	0	0	92%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.